• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    27 Stocks Moving in Thursday's Pre-Market Session

    6/16/22 6:58:04 AM ET
    $ACIU
    $AEI
    $APLT
    $BARK
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Real Estate
    Finance
    Get the next $ACIU alert in real time by email

    Gainers

    • Heart Test Laboratories, Inc. (NASDAQ:HSCS) rose 92.9% to $3.28 in pre-market trading following’s Wednesday IPO.
    • Electric Last Mile Solutions, Inc. (NASDAQ:ELMS) rose 27.1% to $0.1790 in pre-market trading after declining around 15% on Wednesday. Electric Last Mile Solutions recently announced plans to file for Chapter 7 bankruptcy.
    • Senti Biosciences, Inc. (NASDAQ:SNTI) rose 19% to $2.44 in pre-market trading after declining around 15% on Wednesday.
    • Redbox Entertainment Inc. (NASDAQ:RDBX) rose 18.6% to $13.00 in pre-market trading after gaining around 9% on Wednesday.
    • Alset EHome International Inc. (NASDAQ:AEI) rose 17.1% to $0.3560 in pre-market trading.
    • GreenPower Motor Company Inc. (NASDAQ:GP) shares rose 14.5% to $3.88 in pre-market trading.
    • Applied Therapeutics, Inc. (NASDAQ:APLT) rose 12.7% to $1.24 in pre-market trading.
    • Qualigen Therapeutics, Inc. (NASDAQ:QLGN) shares rose 12.2% to $0.68 in pre-market trading after gaining over 4% on Wednesday.
    • Embark Technology, Inc. (NASDAQ:EMBK) rose 11.5% to $0.7267 in pre-market trading.
    • Secoo Holding Limited (NASDAQ:SECO) shares rose 11.1% to $0.25 in pre-market trading after declining 5% on Wednesday.
    • Gamida Cell Ltd. (NASDAQ:GMDA) rose 9.3% to $2.11 in pre-market trading after gaining around 5% on Wednesday.
    • BARK, Inc. (NYSE:BARK) rose 8.9% to $1.59 in pre-market trading.
    • Sidus Space, Inc. (NASDAQ:SIDU) rose 8.5% to $5.08 in pre-market trading. Sidus Space shares jumped 225% on Wednesday after the company announced it is part of Collins Aerospace team which was awarded NASA's Exploration Extravehicular Activity services contract with a potential value of $3.5 billion.
    • Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) rose 8.1% to $3.73 in pre-market trading. Rhythm Pharmaceuticals recently presented initial data from long-term extension trial evaluating setmelanotide in rare genetic diseases of obesity at ENDO 2022.


    Don’t forget to check out our premarket coverage here .

    Losers

    • Cango Inc. (NYSE:CANG) shares fell 29.8% to $2.27 in pre-market trading.
    • AC Immune SA (NASDAQ:ACIU) fell 15.4% to $2.42 in pre-market trading after the company issued an update on Alzheimer’s Prevention Initiative study evaluating crenezumab in Autosomal Dominant Alzheimer’s Disease.
    • Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) fell 14.7% to $1.50 in pre-market trading after surging 8% on Wednesday.
    • Cepton, Inc. (NASDAQ:CPTN) fell 12.4% to $1.27 in pre-market trading. Cepton, is set to join the Russell 3000® Index.
    • Zhong Yang Financial Group Limited (NASDAQ:TOP) shares fell 12.2% to $27.25 in pre-market trading after jumping 41% on Wednesday.
    • Calithera Biosciences, Inc. (NASDAQ:CALA) shares fell 10.9% to $2.45 in pre-market trading. Calithera Biosciences recently announced a 1-for-20 reverse stock split.
    • Kintara Therapeutics, Inc. (NASDAQ:KTRA) shares fell 10.1% to $0.21 in pre-market trading. Kintara Therapeutics shares jumped 25% on Wednesday after the FDA granted Fast Track Designation to the company’s VAL-083.
    • Kaixin Auto Holdings (NASDAQ:KXIN) fell 9.5% to $0.9228 in pre-market trading. Kaixin Auto Holdings recently hired Mr. Lei Gu as the strategic advisor to lead development of its new energy vehicle business.
    • Shoals Technologies Group, Inc. (NASDAQ:SHLS) fell 9.1% to $17.25 in pre-market trading after jumping more than 10% on Wednesday.
    • Koninklijke Philips N.V. (NYSE:PHG) fell 8.9% to $20.59 in pre-market trading.
    • Missfresh Limited (NASDAQ:MF) fell 8.5% to $0.2263 in pre-market trading.
    • ShiftPixy, Inc. (NASDAQ:PIXY) fell 8.5% to $0.2706 in pre-market trading after dipping 15% on Wednesday.
    • Tenon Medical, Inc. (NASDAQ:TNON) fell 8.3% to $2.10 in pre-market trading after jumping over 12% on Wednesday.
    Get the next $ACIU alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACIU
    $AEI
    $APLT
    $BARK

    CompanyDatePrice TargetRatingAnalyst
    Shoals Technologies Group Inc.
    $SHLS
    2/25/2026$9.00Underperform → Neutral
    BNP Paribas Exane
    Rhythm Pharmaceuticals Inc.
    $RYTM
    2/19/2026$478.00Outperform
    RBC Capital Mkts
    Koninklijke Philips N.V. NY Registry Shares
    $PHG
    12/17/2025Sector Perform
    RBC Capital Mkts
    Shoals Technologies Group Inc.
    $SHLS
    12/16/2025$9.50Overweight → Equal-Weight
    Morgan Stanley
    Applied Therapeutics Inc.
    $APLT
    12/12/2025Outperform → Neutral
    Robert W. Baird
    Xeris Biopharma Holdings Inc.
    $XERS
    12/9/2025$9.00Overweight
    Barclays
    Applied Therapeutics Inc.
    $APLT
    12/3/2025$1.00Outperform → Market Perform
    Leerink Partners
    Rhythm Pharmaceuticals Inc.
    $RYTM
    11/25/2025$136.00Buy
    Citigroup
    More analyst ratings

    $ACIU
    $AEI
    $APLT
    $BARK
    SEC Filings

    View All

    SEC Form DEFA14A filed by Xeris Biopharma Holdings Inc.

    DEFA14A - Xeris Biopharma Holdings, Inc. (0001867096) (Filer)

    4/23/26 5:08:46 PM ET
    $XERS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form DEF 14A filed by Xeris Biopharma Holdings Inc.

    DEF 14A - Xeris Biopharma Holdings, Inc. (0001867096) (Filer)

    4/23/26 5:08:00 PM ET
    $XERS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by Cango Inc.

    6-K - Cango Inc. (0001725123) (Filer)

    4/22/26 4:04:20 PM ET
    $CANG
    Computer Software: Prepackaged Software
    Technology

    $ACIU
    $AEI
    $APLT
    $BARK
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Chan Heng Fai Ambrose bought $42,527 worth of shares (33,000 units at $1.29), increasing direct ownership by 0.10% to 31,822,903 units (SEC Form 4)

    4 - Alset Inc. (0001750106) (Issuer)

    8/19/25 4:15:23 PM ET
    $AEI
    Real Estate
    Finance

    Chief Financial Officer Ibrahim Zahir bought $50,523 worth of shares (58,823 units at $0.86) (SEC Form 4)

    4 - Bark, Inc. (0001819574) (Issuer)

    6/16/25 4:27:36 PM ET
    $BARK
    Other Specialty Stores
    Consumer Discretionary

    Officer Mcculloch Kevin bought $109,475 worth of shares (25,000 units at $4.38), increasing direct ownership by 1% to 1,708,585 units (SEC Form 4)

    4 - Xeris Biopharma Holdings, Inc. (0001867096) (Issuer)

    6/16/25 4:26:02 PM ET
    $XERS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACIU
    $AEI
    $APLT
    $BARK
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    April 17, 2023 - FDA Approves Cell Therapy for Patients with Blood Cancers to Reduce Risk of Infection Following Stem Cell Transplantation

    For Immediate Release: April 17, 2023 Today, the U.S. Food and Drug Administration approved Omisirge (omidubicel-onlv), a substantially modified allogeneic (donor) cord blood-based cell therapy to quicken the recovery of neutrophils (a subset of white blood cells) in the body and reduce the risk of infection. The product is intended for use in adults and pediatric patients 12 years and older with blood cancers p

    4/17/23 1:02:15 PM ET
    $GMDA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ACIU
    $AEI
    $APLT
    $BARK
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Philips launches new Bridge Plus Occlusion Balloon to help manage rare but life-threatening SVC tears during lead extraction

    April 23, 2026   Bridge Plus was designed for rare, life-threatening emergencies to help control bleeding during superior vena cava (SVC) tears, which occur in <0.5% of lead extraction procedures [1] but require immediate intervention Bridge Plus allows for rapid response when every second counts by deploying in under two minutes [2] and stopping up to 90% blood loss [3], helping stabilize patients with 30 minutes of hemostasis [4]Bridge Plus was built upon proven Bridge Occlusion Balloon technology, used in more than 50,000 U.S. procedures [5,*], with evidence showing improved survival when staged in advance [6,**] Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), a globa

    4/23/26 9:00:00 AM ET
    $PHG
    Medical Electronics
    Health Care

    Sidus Space Advances its Fortis Next-Generation Command and Data Handling (C&DH) System

    Microchip collaboration enables accelerated, modular, and mission‑scalable OpenVPX architectures for space and defense applications CAPE CANAVERAL, Fla., April 23, 2026 /PRNewswire/ -- Sidus Space, Inc. (NASDAQ:SIDU) ("Sidus" or the "Company"), an innovative space and defense technology company, today announced continued advancements to its Fortis Command and Data Handling (C&DH) platform, a modular 3U OpenVPX system designed to support rapid development, configuration flexibility, and long-term scalability across next-generation space and defense missions. Supported by a strate

    4/23/26 8:31:00 AM ET
    $SIDU
    Telecommunications Equipment
    Telecommunications

    Xeris Biopharma to Report First Quarter 2026 Financial Results on May 7, 2026

    Conference Call to be Held at 8:30 a.m. ET Xeris Biopharma Holdings, Inc. (NASDAQ:XERS), a fast-growing biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies, today announced that the Company will release its first quarter 2026 financial results before the open of the U.S. financial markets on Thursday, May 7, 2026. Management will host a conference call and webcast at 8:30 a.m. Eastern Time that day to discuss the Company's financial and operational results. Interested parties may pre-register for the call here or via the "Events" section of the Investor Relations website. It is recommended that

    4/23/26 7:30:00 AM ET
    $XERS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACIU
    $AEI
    $APLT
    $BARK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Shoals Technologies upgraded by BNP Paribas Exane with a new price target

    BNP Paribas Exane upgraded Shoals Technologies from Underperform to Neutral and set a new price target of $9.00

    2/25/26 7:38:45 AM ET
    $SHLS
    Semiconductors
    Technology

    RBC Capital Mkts initiated coverage on Rhythm Pharmaceuticals with a new price target

    RBC Capital Mkts initiated coverage of Rhythm Pharmaceuticals with a rating of Outperform and set a new price target of $478.00

    2/19/26 7:52:12 AM ET
    $RYTM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    RBC Capital Mkts initiated coverage on Philips

    RBC Capital Mkts initiated coverage of Philips with a rating of Sector Perform

    12/17/25 9:26:42 AM ET
    $PHG
    Medical Electronics
    Health Care

    $ACIU
    $AEI
    $APLT
    $BARK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: SEC Form 4 filed by Pfeifer Andrea

    4/A - AC Immune SA (0001651625) (Issuer)

    4/16/26 12:39:29 PM ET
    $ACIU
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Pfeifer Andrea

    4 - AC Immune SA (0001651625) (Issuer)

    4/16/26 11:10:49 AM ET
    $ACIU
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Black Michael Scott

    4 - Bark, Inc. (0001819574) (Issuer)

    4/14/26 4:34:19 PM ET
    $BARK
    Other Specialty Stores
    Consumer Discretionary

    $ACIU
    $AEI
    $APLT
    $BARK
    Leadership Updates

    Live Leadership Updates

    View All

    Rhythm Pharmaceuticals Announces Changes to Board of Directors

    -- Kim Popovits appointed as new Director; Ed Mathers to depart -- BOSTON, April 03, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced changes to its Board of Directors, including the appointment of Kim Popovits and the departure of Ed Mathers. "We are thrilled to welcome Kim to our Board of Directors," said David Meeker, M.D., Chairman, President and Chief Executive Officer of Rhythm. "Kim brings decades of leadership experience across biotechnology, diagnostics and commercial innovation, with a proven track record

    4/3/26 9:00:00 AM ET
    $RYTM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Philips proposes new appointment and re-appointments to its Supervisory Board and CEO re-appointment

    March 23, 2026 John DeFord proposed as new member of the Supervisory Board.Paul Stoffels, Herna Verhagen and Sanjay Poonen proposed for re-appointment as members of the Supervisory Board.Marc Harrison will step down from Philips' Supervisory Board after his second term.Roy Jakobs proposed for re-appointment as President/CEO and Chairman and member of the Board of Management, as previously announced. Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), a global leader in health technology, today announced a proposed Supervisory Board appointment and re-appointments, in addition to the previously announced proposal to re-appointment its President/CEO. The Supervisory Board wil

    3/23/26 4:30:00 AM ET
    $PHG
    Medical Electronics
    Health Care

    Philips proposes to re-appoint CEO Roy Jakobs

    February 10, 2026 Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), a global leader in health technology, today announced that Roy Jakobs is proposed to be re-appointed as its President/Chief Executive Officer and member of the Board of Management. The decision to propose the re-appointment of Roy Jakobs reflects the Supervisory Board's recognition of the progress made since 2022 and its confidence in his leadership as Philips enters the next phase of driving profitable growth. The proposal will be submitted for approval at the upcoming Annual General Meeting of Shareholders (AGM), to be held on May 8, 2026. "Roy Jakobs has demonstrated clear leadership, strong execution

    2/10/26 12:55:00 AM ET
    $PHG
    Medical Electronics
    Health Care

    $ACIU
    $AEI
    $APLT
    $BARK
    Financials

    Live finance-specific insights

    View All

    Xeris Biopharma to Report First Quarter 2026 Financial Results on May 7, 2026

    Conference Call to be Held at 8:30 a.m. ET Xeris Biopharma Holdings, Inc. (NASDAQ:XERS), a fast-growing biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies, today announced that the Company will release its first quarter 2026 financial results before the open of the U.S. financial markets on Thursday, May 7, 2026. Management will host a conference call and webcast at 8:30 a.m. Eastern Time that day to discuss the Company's financial and operational results. Interested parties may pre-register for the call here or via the "Events" section of the Investor Relations website. It is recommended that

    4/23/26 7:30:00 AM ET
    $XERS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Rhythm Pharmaceuticals to Report First Quarter 2026 Financial Results on Tuesday, May 5, 2026

    BOSTON, April 09, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced that it will host a live conference call and webcast at 8 a.m. ET on Tuesday, May 5, 2026 to report its first quarter 2026 financial results and provide a corporate update. Also today, Rhythm announced that Hunter Smith, Chief Financial Officer, will participate in a fireside chat at the 25th Annual Needham Virtual Healthcare Conference on Thursday, April 16, 2026, at 11:00 a.m. ET. Live webcasts of both the financial results conference call and the

    4/9/26 8:00:00 AM ET
    $RYTM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Shoals Technologies Group, Inc. Announces First Quarter 2026 Earnings Release Date and Conference Call

    PORTLAND, Tenn., April 09, 2026 (GLOBE NEWSWIRE) -- Shoals Technologies Group, Inc. (the "Company") (NASDAQ:SHLS) today announced that the Company will release its first quarter 2026 results before market open on Tuesday, May 5, 2026, to be followed by a conference call at 8:00 a.m. (Eastern Time) on the same day. Interested investors and other parties can access the live webcast through the Investor Relations section of the Company's website at https://investors.shoals.com. An archived replay of the webcast will be available shortly after the event concludes. About Shoals Technologies Group, Inc.Shoals Technologies Group is a leading manufacturer of advanced electrical infrastructure so

    4/9/26 7:00:00 AM ET
    $SHLS
    Semiconductors
    Technology

    $ACIU
    $AEI
    $APLT
    $BARK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by AC Immune SA

    SC 13G/A - AC Immune SA (0001651625) (Subject)

    12/13/24 5:15:16 PM ET
    $ACIU
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Rhythm Pharmaceuticals Inc.

    SC 13G - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Subject)

    11/14/24 9:50:26 PM ET
    $RYTM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Sidus Space Inc.

    SC 13G/A - Sidus Space Inc. (0001879726) (Subject)

    11/14/24 7:31:47 PM ET
    $SIDU
    Telecommunications Equipment
    Telecommunications